HHS launches historic crackdown on organ donation system, decertifies OPO mid-cycle

The Department of Health and Human Services announced Thursday that it is decertifying a major organ procurement organization mid-cycle, a move officials describe as historic as part of a broader effort to overhaul the nation’s organ donation system. The Life Alliance Organ Recovery Agency, based in Miami, was cited for deficiencies tied to patient harm as the department moves to tighten oversight and safety standards. "Every American should feel safe becoming an organ donor and giving the gift of life," HHS Secretary Robert F. Kennedy Jr. said. "Yet decades of ignored patient safety concerns have driven more Americans off the donor list. Today, under President Trump’s leadership, we are taking bold action and historic action to restore trust in the organ procurement process."

For the first time in U.S. history, the department is pursuing mid-cycle decertification of an organ procurement organization, officials said. Kennedy added that the Life Alliance Organ Recovery Agency has a long record of deficiencies directly tied to patient harm, and staffing shortfalls alone may have caused as many as eight missed organ recoveries each week, roughly one life lost each day.

Dr. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, underscored the gravity of the situation, noting that about 100,000 people are on the organ waiting list. "While I’m speaking, another person will be added to that list. During this press conference, someone waiting for an organ is going to die," Oz said. He noted that 28,000 donated organs go unmatched and discarded each year, a rate he called a "tragedy" of waste.

New investments include $25 million to support living donors by covering nonmedical costs such as lost wages, travel and childcare. Dr. Marty Makary, commissioner of the Food and Drug Administration, called the waste of organs "a tragedy" and said the reforms send a tough message to other OPOs: "There’s a new sheriff in town, and we’re coming for them if they don’t take care of the American people."

Thomas J. Engels, administrator of the Health Resources and Services Administration, said modernization is underway and that the administration has opened a "direct reporting channel for misconduct and safety concerns." He added that a broader set of reforms will expand oversight and accountability across the organ procurement system.

Experts pointed to the future of transplant science, citing moves toward the first clinical trials for xenotransplantation (animal-to-human transplants) and the potential for 3D-printed organs to someday supplement or replace donor tissue.

The Life Alliance Organ Recovery Agency issued a statement on its website saying it will cooperate with HHS during the transition and that its focus remains on protecting donors' dignity, supporting their families and advancing the life-saving mission of transplantation.